Dabigatran v warfarin. Compare with higher standard.

Suppr

超能文献

作者信息

Edwards Duncan

出版信息

BMJ. 2010 Oct 26;341:c5984. doi: 10.1136/bmj.c5984.

DOI:10.1136/bmj.c5984

PMID:20978048

Abstract

摘要

相似文献

Dabigatran v warfarin. Compare with higher standard.

BMJ. 2010 Oct 26;341:c5984. doi: 10.1136/bmj.c5984.

Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.

Expert Opin Pharmacother. 2010 Mar;11(4):685-7. doi: 10.1517/14656560903530691.

Should dabigatran replace warfarin for stroke prevention in AF?

Drug Ther Bull. 2011 Oct;49(10):114-7. doi: 10.1136/dtb.2011.02.0060.

Dabigatran in clinical practice.

Clin Ther. 2012 Oct;34(10):2051-60. doi: 10.1016/j.clinthera.2012.09.008. Epub 2012 Sep 29.

Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.

Nurse Pract. 2011 Sep;36(9):6-7. doi: 10.1097/01.NPR.0000403296.82092.fb.

[Dabigatran: beyond the RE-LY study].

Rev Clin Esp. 2012 Mar;212 Suppl 2:1-3. doi: 10.1016/S0014-2565(12)70012-7.

Warfarin: is the end nigh? Please?

J R Coll Physicians Edinb. 2010 Sep;40(3):222-3. doi: 10.4997/JRCPE.2010.322.

What are the emerging therapeutic alternatives to warfarin in stroke patients? How would the results of RE-LY benefit Pakistanis?

J Pak Med Assoc. 2011 Jun;61(6):612-3.

Quality of anticoagulation control in atrial fibrillation.

Lancet. 2010 Sep 18;376(9745):935-7. doi: 10.1016/S0140-6736(10)61305-0.

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.

Circulation. 2010 Nov 30;122(22):2246-53. doi: 10.1161/CIRCULATIONAHA.110.973735.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Dabigatran v warfarin. Compare with higher standard.

BMJ. 2010 Oct 26;341:c5984. doi: 10.1136/bmj.c5984.

Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.

Expert Opin Pharmacother. 2010 Mar;11(4):685-7. doi: 10.1517/14656560903530691.

Should dabigatran replace warfarin for stroke prevention in AF?

Drug Ther Bull. 2011 Oct;49(10):114-7. doi: 10.1136/dtb.2011.02.0060.

Dabigatran in clinical practice.

Clin Ther. 2012 Oct;34(10):2051-60. doi: 10.1016/j.clinthera.2012.09.008. Epub 2012 Sep 29.

Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.

Nurse Pract. 2011 Sep;36(9):6-7. doi: 10.1097/01.NPR.0000403296.82092.fb.

[Dabigatran: beyond the RE-LY study].

Rev Clin Esp. 2012 Mar;212 Suppl 2:1-3. doi: 10.1016/S0014-2565(12)70012-7.

Warfarin: is the end nigh? Please?

J R Coll Physicians Edinb. 2010 Sep;40(3):222-3. doi: 10.4997/JRCPE.2010.322.

What are the emerging therapeutic alternatives to warfarin in stroke patients? How would the results of RE-LY benefit Pakistanis?

J Pak Med Assoc. 2011 Jun;61(6):612-3.

Quality of anticoagulation control in atrial fibrillation.

Lancet. 2010 Sep 18;376(9745):935-7. doi: 10.1016/S0140-6736(10)61305-0.

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.

Circulation. 2010 Nov 30;122(22):2246-53. doi: 10.1161/CIRCULATIONAHA.110.973735.